ELI LILLY & Co is 579.9x more valuable than ASCENTAGE PHARMA GROUP INTERNATIONAL by market capitalization ($1.067 T vs $1.84 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AAPG | LLY |
|---|---|---|
| Market cap | $1.84 B | $1.067 T |
| US-listed rank | #2171 | #11 |
| Revenue (latest FY) | - | $65.18B |
| Net income (latest FY) | - | $20.64B |
| Net margin | - | 31.7% |
| P/E (trailing FY) | - | 51.7 |
| SEC filings | 111 | 989 |
ELI LILLY & Co is 579.9x more valuable than ASCENTAGE PHARMA GROUP INTERNATIONAL by market capitalization ($1.067 T vs $1.84 B).
Full pages: ASCENTAGE PHARMA GROUP INTERNATIONAL and ELI LILLY & Co, or browse the full rankings.